Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Agios Pharmaceuticals Inc (NASDAQ: AGIO) was $36.16 for the day, up 3.31% from the previous closing price of $35.0. In other words, the price has increased by $3.31 from its previous closing price. On the day, 5.5 million shares were traded. AGIO stock price reached its highest trading level at $36.38 during the session, while it also had its lowest trading level at $26.7517.
Ratios:
Our analysis of AGIO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.04 and its Current Ratio is at 14.48. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $58.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 10 ’25 when Scadden David sold 1,400 shares for $40.00 per share. The transaction valued at 56,000 led to the insider holds 17,603 shares of the business.
Gheuens Sarah sold 11,914 shares of AGIO for $452,601 on Jul 09 ’25. The Chief Medical Officer now owns 61,271 shares after completing the transaction at $37.99 per share. On Jul 10 ’25, another insider, DAVID SCADDEN, who serves as the Director of the company, bought 1,400 shares for $40.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGIO now has a Market Capitalization of 2100950272 and an Enterprise Value of 1210773888. As of this moment, Agios’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 51.39 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 29.621 whereas that against EBITDA is -2.654.
Stock Price History:
The Beta on a monthly basis for AGIO is 0.88, which has changed by -0.15137291 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, AGIO has reached a high of $62.58, while it has fallen to a 52-week low of $23.42. The 50-Day Moving Average of the stock is 1.68%, while the 200-Day Moving Average is calculated to be -1.96%.
Shares Statistics:
AGIO traded an average of 649.31K shares per day over the past three months and 1384820 shares per day over the past ten days. A total of 58.04M shares are outstanding, with a floating share count of 55.56M. Insiders hold about 4.37% of the company’s shares, while institutions hold 104.56% stake in the company. Shares short for AGIO as of 1752537600 were 4179173 with a Short Ratio of 6.44, compared to 1749772800 on 4323656. Therefore, it implies a Short% of Shares Outstanding of 4179173 and a Short% of Float of 7.249999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
